Literature DB >> 3418785

Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo.

B C Guild1, M H Finer, D E Housman, R C Mulligan.   

Abstract

A series of retrovirus vectors were constructed in which cellular promoter elements derived from the chicken beta-actin and human histone H4 genes were introduced within the proviral transcriptional unit of Moloney murine leukemia virus in order to promote expression of inserted sequences. Each of these vectors gave rise to high titer of virus capable of transferring the expected proviral structure to cells. Inclusion of normal 5' splice sequences or a portion of viral gag sequences in these constructions resulted in significant increases in virus titer. Each construction was transcriptionally active in NIH 3T3 cells and in undifferentiated F9 cells. One of the vectors, HSG-neo, which contained the human histone H4 promoter, was shown to be transcriptionally active in hematopoietic cells derived from long-term reconstituted bone marrow transplant recipients engrafted with transduced stem cells. These vectors should be of general use for obtaining efficient gene expression in embryonal and hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418785      PMCID: PMC253524          DOI: 10.1128/JVI.62.10.3795-3801.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

2.  The nucleotide sequence of the chick cytoplasmic beta-actin gene.

Authors:  T A Kost; N Theodorakis; S H Hughes
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells.

Authors:  E Linney; B Davis; J Overhauser; E Chao; H Fan
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

5.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

6.  Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells.

Authors:  A Joyner; G Keller; R A Phillips; A Bernstein
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  Expression and regulation of chicken actin genes introduced into mouse myogenic and nonmyogenic cells.

Authors:  A Seiler-Tuyns; J D Eldridge; B M Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer.

Authors:  P W Kantoff; A P Gillio; J R McLachlin; C Bordignon; M A Eglitis; N A Kernan; R C Moen; D B Kohn; S F Yu; E Karson
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  33 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Packaging system for rapid production of murine leukemia virus vectors with variable tropism.

Authors:  N R Landau; D R Littman
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells.

Authors:  P Soriano; G Friedrich; P Lawinger
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Retroviral mediated gene transfer into bone marrow progenitor cells: use of beta-galactosidase as a selectable marker.

Authors:  R K Strair; M Towle; B R Smith
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

5.  Purification and characterization of retrovirally transduced hematopoietic stem cells.

Authors:  L M Spain; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

6.  Analysis of rice Act1 5' region activity in transgenic rice plants.

Authors:  W Zhang; D McElroy; R Wu
Journal:  Plant Cell       Date:  1991-11       Impact factor: 11.277

7.  Reducing the genotoxic potential of retroviral vectors.

Authors:  Ali Ramezani; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2008

8.  Construction of retroviral vectors with improved safety, gene expression, and versatility.

Authors:  S H Kim; S S Yu; J S Park; P D Robbins; C S An; S Kim
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.

Authors:  N Cartier; J Lopez; P Moullier; F Rocchiccioli; M O Rolland; P Jorge; J Mosser; J L Mandel; P F Bougnères; O Danos
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Development of a retroviral vector for inducible expression of transforming growth factor beta 1.

Authors:  M L McGeady; P M Arthur; M Seidman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.